2025 年全球臨床微生物學市場報告

預計未來幾年臨床微生物學市場規模將強勁成長。到 2029 年，這一數字將成長到 103.1 億美元，年複合成長率（CAGR）為 8.7%。預測期內的成長將受到對快速結果的需求、對個人化治療的重視、對監測的不斷成長的需求、對醫療相關感染的關注以及對就地檢驗的整合的推動。預測期內的主要趨勢包括體學技術的整合、協作創新、醫療相關感染意識、監管影響和技術進步。

感染疾病率的上升預計將推動臨床微生物學市場的成長。感染疾病是由細菌、真菌和寄生蟲等有害微生物引起的疾病。臨床微生物學在分離和表徵這些傳染性病原體以管理和治療患者疾病方面發揮著至關重要的作用。例如，2024年5月，總部設在瑞士的政府間組織世界衛生組織（WHO）報告稱，2022年全球新增愛滋病毒感染人數為130萬（範圍：10萬至170萬）。這比先前報告的 280 萬感染人數大幅下降了 54%。因此，感染疾病的增加促進了臨床微生物學市場的擴大。

由於公共和私人對臨床診斷的投資不斷增加，臨床微生物學市場將會成長。兩個部門的資金增加將促進診斷工具、檢測能力和感染疾病公共衛生應對措施的進步。英國政府承諾自 2023 年 2 月起增加對醫療設備認證的投資，就反映了這一趨勢。 MedTech news 報告稱，2023 年私募股權對醫療科技產業的投資將達到 1,118 億美元，這進一步推動了臨床診斷整體資金籌措的激增，凸顯了臨床微生物學市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球臨床微生物學 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球臨床微生物學市場：成長率分析
• 全球臨床微生物學市場表現：規模與成長，2019 年至 2024 年
• 全球臨床微生物學市場預測：2024-2029 年及 2034 年規模與成長
• 全球臨床微生物學總目標市場 (TAM)

第6章 市場細分

• 2019-2024 年、2024-2029 年、2034 年全球臨床微生物學市場（按產品、性能和預測）
• 實驗室設備
• 微生物分析儀
• 試劑
• 全球臨床微生物學市場（依適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 呼吸系統疾病
• 性行為感染傳染病
• 尿道感染
• 牙周病
• 其他疾病
• 全球臨床微生物學市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
• 醫院
• 診斷實驗室
• 其他最終用戶
• 全球臨床微生物學市場：實驗室儀器細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 培養箱
• 高壓釜
• 顯微鏡
• 培養基製備設備
• 全球臨床微生物學市場：微生物分析儀細分市場、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 自動化分析設備
• 質譜儀
• PCR分析設備
• 全球臨床微生物學市場：試劑細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 培養基
• 染色劑和染料
• 抗體
• 診斷套件

第7章 區域和國家分析

• 全球臨床微生物學市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球臨床微生物學市場：依國家、績效與預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 臨床微生物學市場：競爭格局
• 臨床微生物學市場：公司簡介
  • bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• QIAGEN NV
• 3M
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Hologic Inc.
• Agilent Technologies Inc.
• Merck Group
• Shimadzu Corporation
• Neogen Corporation
• Vacutest Kima SRL
• Arrow Diagnostics SRL
• OpGen
• Becton Dickinson and Company
• Johnson & Johnson
• Sanofi SA

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年臨床微生物學市場：提供新機會的國家
• 2029 年臨床微生物學市場：細分市場將帶來新機會
• 2029 年臨床微生物學市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Clinical microbiology is a branch of medical science that encompasses a wide range of testing methodologies, methods for isolating and identifying various microorganisms, and the application of microbes in clinical settings to improve health.

The main products associated with clinical microbiology include laboratory instruments, microbiology analyzers, and reagents. Laboratory instruments are employed for various laboratory operations such as diagnostics, experiments, and analysis. These instruments, which include vessels and tools, are used in laboratory settings without altering the physical and chemical properties of the products involved in operations. Clinical microbiology plays a crucial role in detecting indications related to respiratory diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other health conditions. The products in this field find application in hospitals, diagnostic laboratories, and other end-users involved in healthcare and medical research.

The clinical microbiology market research report is one of a series of new reports from The Business Research Company that provides clinical microbiology market statistics, including clinical microbiology industry global market size, regional shares, competitors with a clinical microbiology market share, detailed clinical microbiology market segments, market trends and opportunities, and any further data you may need to thrive in the clinical microbiology industry. This clinical microbiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical microbiology market size has grown strongly in recent years. It will grow from $6.95 billion in 2024 to $7.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rise of antimicrobial resistance, infectious disease outbreaks, globalization and travel, aging population, increased healthcare expenditure.

The clinical microbiology market size is expected to see strong growth in the next few years. It will grow to $10.31 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to demand for rapid results, focus on personalized treatments, increasing demand for surveillance, emphasis on healthcare-associated infections, integration of point-of-care testing. Major trends in the forecast period include omics technology integration, collaborative innovation, healthcare-associated infections awareness, regulatory influence, technological advancements.

The rising incidence of infectious diseases is anticipated to drive growth in the clinical microbiology market. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, fungi, and parasites. Clinical microbiology plays a crucial role in isolating and characterizing these infectious agents to manage and treat diseases in patients. For example, in May 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that there were 1.3 million (with a range of 1.0 to 1.7 million) new HIV infections worldwide in 2022. This marks a significant 54% reduction from the 2.8 million infections reported in previous years. Thus, the increasing prevalence of infectious diseases is contributing to the expansion of the clinical microbiology market.

The clinical microbiology market is set for growth propelled by the augmented public and private investments in clinical diagnostics. Increased funding from both sectors acts as a catalyst for advancements in diagnostic tools, laboratory capabilities, and public health responses to infectious diseases. The UK government's commitment to enhanced investment in medical device approval, as of February 2023, is indicative of this trend. Private equity investments of $111.8 billion in the healthTech industry in 2023, as reported by MedTech news, further contribute to the overall funding surge in clinical diagnostics, substantiating the growth of the clinical microbiology market.

Leading companies in the clinical microbiology market are increasingly allocating resources toward innovative diagnostic technologies and automation systems, including advanced laboratory automation solutions and next-generation sequencing, to boost pathogen detection efficiency and enhance patient care outcomes. One notable example is the new third-generation BD Kiestra Total Lab Automation System, an advanced robotic track system tailored for microbiology laboratories. This system allows for customizable automation configurations that streamline specimen processing, from inoculation to pathogen detection. For instance, in January 2023, Becton, Dickinson and Company, a U.S.-based medical device firm, introduced the third-generation BD Kiestra Total Lab Automation System specifically for microbiology laboratories. This robotic track system is compatible with the BD Kiestra microbiology laboratory solution, which automates lab specimen processing. Designed to address the evolving needs of laboratories, this new robotic track system facilitates the creation of a custom and flexible total lab automation setup that can connect multiple BD Kiestra modules.

Product innovations take center stage in the clinical microbiology market, with major companies focusing on developing new solutions to enhance patient care. Middleware systems like MAESTRIA are designed to revolutionize workflow management within clinical microbiology laboratories. Launched by bioMerieux in January 2023, MAESTRIA offers features such as workflow management, biological expertise, and data management, streamlining laboratory processes and optimizing surveillance reporting. The middleware is compatible with existing instruments and workflows, providing an integrated solution for microbiology laboratory processes.

Strategic acquisitions play a vital role in shaping the clinical microbiology market landscape. In April 2022, DCN Dx, a US-based company specializing in rapid point-of-care tests, acquired Biomed Diagnostics Inc. This acquisition aims to bolster DCN Diagnostics' product portfolio and market presence in microbial testing within the clinical microbiology domain. Biomed Diagnostics, a US-based manufacturer known for high-quality microbiology devices, adds valuable capabilities to DCN Dx, positioning them for growth in the clinical microbiology market.

Major companies operating in the clinical microbiology market are bioMerieux SA, Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Corporation, QIAGEN NV, 3M, Bio-Rad Laboratories Inc., Bruker Corporation, Hologic Inc., Agilent Technologies Inc., Merck Group, Shimadzu Corporation, Neogen Corporation, Vacutest Kima SRL, Arrow Diagnostics SRL, OpGen, Becton Dickinson and Company, Johnson & Johnson, Sanofi SA, Illumina Inc., Medtronic, Cepheid Inc., Quidel Corporation, Luminex Corporation, DiaSorin S.p.A., GenMark Diagnostics Inc., T2 Biosystems Inc., Nanosphere Health Sciences Inc.

North America was the largest region in the clinical microbiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical microbiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical microbiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical microbiology market consists of sales of incubators, gram strainers, bacterial colony counters, autoclave sterilizers, microbial air samplers, and anaerobic culture systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Microbiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical microbiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical microbiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical microbiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Laboratory Instruments; Microbiology Analyzers; Reagents
• 2) By Indication: Respiratory Diseases; Sexually Transmitted Diseases; Urinary Tract infections; Periodontal Diseases; Other Diseases
• 3) By End-user: Hospitals; Diagnostic Laboratories; Other End-user
• Subsegments:
• 1) By Laboratory Instruments: Incubators; Autoclaves; Microscopes; Culture Media Preparation Equipment
• 2) By Microbiology Analyzers: Automated Analyzers; Mass Spectrometry Analyzers; PCR Analyzers
• 3) By Reagents: Culture Media; Stains And Dyes; Antibodies; Diagnostic Kits
• Companies Mentioned: bioMerieux SA; Danaher Corporation; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Microbiology Market Characteristics

3. Clinical Microbiology Market Trends And Strategies

4. Clinical Microbiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Clinical Microbiology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Clinical Microbiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Clinical Microbiology Market Growth Rate Analysis
• 5.4. Global Clinical Microbiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Clinical Microbiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Clinical Microbiology Total Addressable Market (TAM)

6. Clinical Microbiology Market Segmentation

• 6.1. Global Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Instruments
• Microbiology Analyzers
• Reagents
• 6.2. Global Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory Diseases
• Sexually Transmitted Diseases
• Urinary Tract infections
• Periodontal Diseases
• Other Diseases
• 6.3. Global Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Other End-user
• 6.4. Global Clinical Microbiology Market, Sub-Segmentation Of Laboratory Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Incubators
• Autoclaves
• Microscopes
• Culture Media Preparation Equipment
• 6.5. Global Clinical Microbiology Market, Sub-Segmentation Of Microbiology Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Mass Spectrometry Analyzers
• PCR Analyzers
• 6.6. Global Clinical Microbiology Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture Media
• Stains And Dyes
• Antibodies
• Diagnostic Kits

7. Clinical Microbiology Market Regional And Country Analysis

• 7.1. Global Clinical Microbiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Clinical Microbiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Microbiology Market

• 8.1. Asia-Pacific Clinical Microbiology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Microbiology Market

• 9.1. China Clinical Microbiology Market Overview
• 9.2. China Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Microbiology Market

• 10.1. India Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Microbiology Market

• 11.1. Japan Clinical Microbiology Market Overview
• 11.2. Japan Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Microbiology Market

• 12.1. Australia Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Microbiology Market

• 13.1. Indonesia Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Microbiology Market

• 14.1. South Korea Clinical Microbiology Market Overview
• 14.2. South Korea Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Microbiology Market

• 15.1. Western Europe Clinical Microbiology Market Overview
• 15.2. Western Europe Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Microbiology Market

• 16.1. UK Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Microbiology Market

• 17.1. Germany Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Microbiology Market

• 18.1. France Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Microbiology Market

• 19.1. Italy Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Microbiology Market

• 20.1. Spain Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Microbiology Market

• 21.1. Eastern Europe Clinical Microbiology Market Overview
• 21.2. Eastern Europe Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Microbiology Market

• 22.1. Russia Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Microbiology Market

• 23.1. North America Clinical Microbiology Market Overview
• 23.2. North America Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Microbiology Market

• 24.1. USA Clinical Microbiology Market Overview
• 24.2. USA Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Microbiology Market

• 25.1. Canada Clinical Microbiology Market Overview
• 25.2. Canada Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Microbiology Market

• 26.1. South America Clinical Microbiology Market Overview
• 26.2. South America Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Microbiology Market

• 27.1. Brazil Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Microbiology Market

• 28.1. Middle East Clinical Microbiology Market Overview
• 28.2. Middle East Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Microbiology Market

• 29.1. Africa Clinical Microbiology Market Overview
• 29.2. Africa Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Microbiology Market Competitive Landscape And Company Profiles

• 30.1. Clinical Microbiology Market Competitive Landscape
• 30.2. Clinical Microbiology Market Company Profiles
  • 30.2.1. bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Thermo Fisher Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Microbiology Market Other Major And Innovative Companies

• 31.1. QIAGEN NV
• 31.2. 3M
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Bruker Corporation
• 31.5. Hologic Inc.
• 31.6. Agilent Technologies Inc.
• 31.7. Merck Group
• 31.8. Shimadzu Corporation
• 31.9. Neogen Corporation
• 31.10. Vacutest Kima SRL
• 31.11. Arrow Diagnostics SRL
• 31.12. OpGen
• 31.13. Becton Dickinson and Company
• 31.14. Johnson & Johnson
• 31.15. Sanofi SA

32. Global Clinical Microbiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Microbiology Market

34. Recent Developments In The Clinical Microbiology Market

35. Clinical Microbiology Market High Potential Countries, Segments and Strategies

• 35.1 Clinical Microbiology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Clinical Microbiology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Clinical Microbiology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer